Related Experiment Video
Updated: Jan 27, 2026

Controlled Cortical Impact Model for Traumatic Brain Injury
Published on: August 5, 2014
Plasma osteopontin may predict neuroinflammation and the severity of pediatric traumatic brain injury
Ning Gao1, Xiaohui Zhang-Brotzge1, Bushra Wali2
1Department of Pediatrics and Center for Neurodegenerative Diseases, Emory University School of Medicine, Atlanta, GA, USA.
Insights
Osteopontin (OPN) shows promise as a blood biomarker for diagnosing and predicting outcomes in pediatric traumatic brain injury (TBI). Plasma OPN levels correlate with TBI severity and patient prognosis, outperforming GFAP.
Area of Science:
- Neuroscience
- Biomarker Discovery
- Pediatric Traumatology
Background:
- Traumatic brain injury (TBI) is a major cause of death in children and adolescents.
- Current diagnostic and prognostic tools for pediatric TBI lack reliable blood-based biomarkers.
- Osteopontin (OPN), a protein secreted by immune cells, is investigated for its potential role.
Purpose of the Study:
- To evaluate plasma osteopontin (OPN) as a diagnostic and prognostic biomarker for pediatric traumatic brain injury (TBI).
- To compare the efficacy of OPN against glial fibrillary acidic protein (GFAP) in pediatric TBI.
- To investigate the correlation of OPN levels with TBI severity, intracranial lesions, and patient outcomes.
Main Methods:
- Animal models of TBI were used to assess OPN, GFAP, and MMP-9 induction after controlled cortical impact.
- Plasma OPN and GFAP levels were measured in pediatric TBI patients (n=66) and correlated with clinical data.
- Longitudinal OPN level monitoring was performed in severe pediatric TBI cases.
Main Results:
- In mice, OPN and GFAP increased in blood correlating with neurological severity scores (NSS).
- In children, plasma OPN, but not GFAP, correlated with severe TBI (Glasgow Coma Score ≤ 8) and intracranial lesions.
- Elevated plasma OPN levels in severe pediatric TBI patients correlated with mortality and need for intensive care.
Conclusions:
- Plasma osteopontin (OPN) demonstrates potential as a diagnostic biomarker for severe pediatric TBI.
- OPN shows superior prognostic value compared to GFAP in pediatric TBI, correlating with mortality and resource utilization.
- OPN may serve as a valuable neuroinflammation-based biomarker for pediatric TBI diagnosis and prognosis.
Abstract:
Traumatic brain injury (TBI) is the leading cause of death in children and adolescents in developed countries, but there are no blood-based biomarkers to support the diagnosis or prognosis of pediatric TBI to-date. Here we report that the plasma levels of osteopontin (OPN), a phosphoprotein chiefly secreted by macrophages and/or activated microglia, may contribute to this goal. In animal models of TBI, while OPN, fibrillary acidic protein (GFAP), and matrix metalloproteinase 9 (MMP-9) were all readily induced by controlled cortical impact in the brains of one-month-old mice, only OPN and GFAP ascended in the blood in correlation with high neurological severity scores (NSS). In children with TBI (three to nine years of age, n = 66), the plasma levels of OPN, but not GFAP, correlated with severe TBI (Glasgow Coma Score ≤ 8) and intracranial lesions at emergency department. In addition, the plasma OPN levels in severe pediatric TBI patients continued to ascend for 72 h and correlated with mortality and the days requiring ventilator or intensive care unit support, whereas the plasma GFAP levels lacked these properties. Together, these results suggest that plasma OPN outperforms GFAP and may be a neuroinflammation-based diagnostic and prognostic biomarker in pediatric TBI.
Related Concept Videos
Predicting Molecular Geometry
Traumatic Memory
Prediction Intervals
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.
Pharmacokinetics in Pediatric Patients: Drug Excretion
End Point Prediction: Gran Plot
For potentiometric titration, the Gran plot is created by plotting...
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...

